[Lani]

6: Fujita T, Doihara H, Washio K, Kawasaki K, Takabatake D, Takahashi H, Tsukuda K, Ogasawara Y, Shimizu N. Related Articles, Links
Proteasome inhibitor bortezomib increases PTEN expression and enhances trastuzumab-induced growth inhibition in trastuzumab-resistant cells.
Anticancer Drugs. 2006 Apr;17(4):455-62.
PMID: 16550004 [PubMed - indexed for MEDLINE]
7: Fujita T, Doihara H, Kawasaki K, Takabatake D, Takahashi H, Washio K, Tsukuda K, Ogasawara Y, Shimizu N. Related Articles, Links
PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer.
Br J Cancer. 2006 Jan 30;94(2):247-52.
PMID: 16404430 [PubMed - indexed for MEDLINE]
8: Lan KH, Lu CH, Yu D. Related Articles, Links
Mechanisms of trastuzumab resistance and their clinical implications.
Ann N Y Acad Sci. 2005 Nov;1059:70-5. Review.
PMID: 16382045 [PubMed - indexed for MEDLINE]
9: Longva KE, Pedersen NM, Haslekas C, Stang E, Madshus IH. Related Articles, Links
Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2.
Int J Cancer. 2005 Sep 1;116(3):359-67.
PMID: 15800944 [PubMed - indexed for MEDLINE]
10: Meric-Bernstam F, Mills GB. Related Articles, Links
Mammalian target of rapamycin.
Semin Oncol. 2004 Dec;31(6 Suppl 16):10-7; discussion 33. Review.
PMID: 15799239 [PubMed - indexed for MEDLINE]
11: Altundag K, Altundag O, Morandi P, Gunduz M. Related Articles, Links
PTEN activation may contribute to exquisite antitumor response to trastuzumab.
Breast. 2005 Apr;14(2):175; author reply 176. No abstract available.
PMID: 15767191 [PubMed - indexed for MEDLINE]
12: Pandolfi PP. Related Articles, Links
Breast cancer--loss of PTEN predicts resistance to treatment.
N Engl J Med. 2004 Nov 25;351(22):2337-8. No abstract available.
PMID: 15564551 [PubMed - indexed for MEDLINE]
13: Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, Hortobagyi GN, Hung MC, Yu D. Related Articles, Links
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.
Cancer Cell. 2004 Aug;6(2):117-27.
PMID: 15324695 [PubMed - indexed for MEDLINE]
14: Crowder RJ, Lombardi DP, Ellis MJ. Related Articles, Links
Successful targeting of ErbB2 receptors-is PTEN the key?
Cancer Cell. 2004 Aug;6(2):103-4.
PMID: 15324690 [PubMed - indexed for MEDLINE]

Easiest way to start is to google Entrez PubMED and put the PMID numbers into the search bar. That will get you abstracts for most, full articles for those that have free access

Hope this helps